Acadia Healthcare (NASDAQ:ACHC) Trading 3.5% Higher - Still a Buy?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report)'s stock price traded up 3.5% on Wednesday . The stock traded as high as $29.63 and last traded at $29.83. 136,794 shares were traded during trading, a decline of 90% from the average session volume of 1,333,360 shares. The stock had previously closed at $28.81.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on ACHC. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a "hold" rating to a "buy" rating and upped their price target for the stock from $45.00 to $75.00 in a report on Thursday, December 12th. Bank of America decreased their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research note on Friday, February 28th. StockNews.com lowered Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Monday, January 6th. Mizuho dropped their price target on Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating on the stock in a research report on Tuesday, March 25th. Finally, KeyCorp decreased their price objective on Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating for the company in a report on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $52.19.

Remove Ads

Acadia Healthcare Stock Performance

The business has a 50-day moving average price of $37.14 and a 200-day moving average price of $45.06. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $2.80 billion, a price-to-earnings ratio of 9.88, a P/E/G ratio of 1.46 and a beta of 1.38.

Hedge Funds Weigh In On Acadia Healthcare

Hedge funds have recently made changes to their positions in the company. Treasurer of the State of North Carolina lifted its stake in Acadia Healthcare by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock worth $1,586,000 after purchasing an additional 250 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after buying an additional 301 shares during the last quarter. Coldstream Capital Management Inc. grew its holdings in Acadia Healthcare by 4.9% in the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock valued at $257,000 after buying an additional 303 shares in the last quarter. Covestor Ltd raised its holdings in shares of Acadia Healthcare by 27.2% during the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock worth $58,000 after acquiring an additional 310 shares during the period. Finally, Pacer Advisors Inc. boosted its position in shares of Acadia Healthcare by 2.4% during the 4th quarter. Pacer Advisors Inc. now owns 13,847 shares of the company's stock valued at $549,000 after acquiring an additional 325 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.